Crane Harbor Acquisition Corp. II (CRAN) Company Overview

US | Financial Services | Financial - Conglomerates | NASDAQ

What does Crane Harbor Acquisition Corp. II do?

Crane Harbor Acquisition Corp. II is a Nasdaq-listed special purpose acquisition company, or SPAC, rather than an operating enterprise with products, customers, and recurring sales. Its Class A ordinary shares trade under CRAN, while its units and share rights trade as CRANU and CRANR. The company was incorporated in the Cayman Islands on June 19, 2025 and exists to identify, negotiate, finance, and close a business combination with one or more operating businesses. The company’s official investor-relations site says the team is particularly interested in technology, real assets, and energy, although the legal mandate permits a transaction in any industry or geography.

$345.0M
IPO gross proceeds, December 17, 2025
34.5M
public units issued in the IPO
$348.5M
trust account at March 31, 2026
Dec. 17, 2027
current business-combination deadline

How should readers classify the business?

Dimension CRAN profile Analytical implication
Economic function Acquisition vehicle with cash in trust Value depends on trust protection, sponsor incentives, target quality, redemptions, and deal terms.
Operating segments One reportable segment; no operating revenue before a deal Traditional segment-margin analysis is not meaningful yet.
Target focus Primary focus on technology, real assets, and energy Management experience and sourcing networks matter more than current product economics.
Listing Nasdaq Global Market: CRAN, CRANU, CRANR The ordinary shares, units, and rights have different risk and dilution profiles.
Blank-check companySingle reportable segmentTrust-backed capitalNo operating revenueSponsor-controlled pre-deal governance

How does Crane Harbor II make money before a business combination?

A pre-deal SPAC has no conventional customer revenue. CRAN’s current income comes from interest on the cash and short-term U.S. government securities held in its trust account. That interest is non-operating income, and it is partly offset by legal, accounting, listing, insurance, administrative, and due-diligence costs. The company’s latest Form 10-Q for the quarter ended March 31, 2026 explicitly states that CRAN will not generate operating revenue until a business combination closes, at the earliest.

What is the economic sequence?

Step 1
Raise public and private capital
The IPO sold 34.5 million units at $10.00, while the sponsor and underwriters bought 900,000 placement units.
Step 2
Protect public capital in trust
A total of $345.0 million was deposited for public shareholders and invested in permitted government securities or cash-like instruments.
Step 3
Search and conduct diligence
Outside-trust cash pays public-company overhead and target-selection costs.
Step 4
Close, redeem, or liquidate
A deal releases remaining trust capital; otherwise public shares are redeemed and rights can expire worthless.
Economic stream Current status What drives it Why it matters
Operating revenue $0 through March 31, 2026 Requires completion of a business combination No customer or product economics exist at the SPAC level today.
Trust interest $3.051M in Q1 2026 Trust balance and short-term interest rates Creates accounting income but is not a durable post-deal earnings stream.
General and administrative cost $0.246M in Q1 2026 Legal, reporting, insurance, diligence, and sponsor services Consumes outside-trust liquidity and can increase as deal activity accelerates.
Post-deal economics Not yet determined Target business, valuation, financing, redemptions, and integration Ultimately determines whether CRAN becomes an attractive operating company.
$0operating revenue through March 31, 2026; reported profit came from trust interest rather than commercial operations.

How is CRAN’s $345 million capital structure designed?

The IPO and private placement create three economically distinct security pools: public Class A shares, private placement Class A shares, and founder Class B shares. The IPO closing Form 8-K confirms 34.5 million public units at $10.00 each, $9.0 million of placement units, and $345.0 million deposited into trust. Each unit contains one Class A share and one right to receive one-fifteenth of a Class A share when a business combination closes.

Gross funding mix at the December 17, 2025 closing
Public IPO — $345.0M — 97.46%
Private placement — $9.0M — 2.54%
The private placement largely funds offering and working-capital needs, while the public capital is protected in trust subject to the governing documents.

Who holds the issued shares before a deal?

46.9M
Public Class A — 34.5M — 73.56%
Founder Class B — 11.5M — 24.52%
Placement Class A — 0.9M — 1.92%
Term Official structure Investor implication
Public redemption value $10.10 per public share at March 31, 2026 Trust interest increased the per-share amount from $10.01 at December 31, 2025.
Share rights One-fifteenth of one Class A share at closing Rights add dilution if a deal closes and expire worthless if the SPAC liquidates.
Founder shares 11.5M Class B shares, generally convertible one-for-one The sponsor has strong upside but a much lower cost basis than public holders.
Deferred underwriting fee $14.7M payable at closing, subject to trust remaining after redemptions Transaction costs reduce cash available to the combined company.
Completion window Through December 17, 2027, unless amended Time pressure rises as the deadline approaches and can affect bargaining power.

The detailed description of securities also explains that public shareholders may redeem while rights holders receive no trust distribution if the SPAC liquidates. This asymmetry is central: shares have a redemption mechanism, but rights are contingent claims on a successful closing.

What did the latest quarter show?

The quarter ended March 31, 2026 was CRAN’s first full quarter after the IPO. It showed a stable trust account, modest public-company overhead, and no announced operating business within CRAN itself. Reported net income was positive because trust interest substantially exceeded administrative expenses. This is financially reassuring for liquidity, but it should not be interpreted as evidence that a future target is profitable.

$348.539M
cash and investments in trust, March 31, 2026
$1.953M
cash outside trust, March 31, 2026
$3.051M
trust interest earned, Q1 2026
$2.805M
net income, Q1 2026
($0.225M)
cash used in operations, Q1 2026
$0.06
basic and diluted EPS for both share classes, Q1 2026

Why is the income statement unusual?

91.9%
Net income as a share of trust interest in Q1 2026. The calculation is $2.805M divided by $3.051M; the remaining 8.1% reflects the general-and-administrative cost burden relative to interest income.
Metric Q1 2026 / March 31, 2026 December 31, 2025 / inception period Interpretation
Trust account $348.539M $345.488M Trust grew by $3.051M, matching Q1 interest earned.
Outside-trust cash $1.953M $2.195M Liquidity declined by $0.242M during Q1 2026.
Total assets $350.731M $347.900M Growth was almost entirely trust interest.
Total liabilities $14.855M $14.830M The $14.7M deferred underwriting fee dominates liabilities.
General and administrative cost $0.246M $0.156M from inception through Dec. 31 Quarterly overhead increased after becoming public.
Net income $2.805M $0.332M from inception through Dec. 31 Income is rate-sensitive and non-operating.
Redemption value per public share $10.10 $10.01 Public-share downside protection increased modestly before taxes and permitted withdrawals.

Which strategic turning points shape CRAN today?

Crane Harbor II has a short corporate history, but each event materially changed its financing, governance, or investor rights. The relevant history is therefore a transaction timeline rather than an operating-company chronology.

  1. June 19, 2025
    The company was incorporated as a Cayman Islands exempted company, establishing the legal vehicle and sponsor relationship.
  2. December 15, 2025
    The IPO registration became effective and the company adopted its amended constitutional documents, trust agreement, rights agreement, and related-party arrangements.
  3. December 17, 2025
    CRAN closed an upsized 34.5 million-unit IPO and $9.0 million private placement; the underwriters exercised the full 4.5 million-unit over-allotment.
  4. January 12, 2026
    The Class A shares and rights began separate Nasdaq trading as CRAN and CRANR, while unsplit units continued as CRANU.
  5. February 27, 2026
    The company filed its first annual report, documenting target criteria, sponsor economics, governance, conflicts, and the December 17, 2027 completion window.
  6. March 31, 2026
    The trust reached $348.539M and the redemption value reached $10.10 per public share, while the company still had no operating revenue.

What does the first Crane Harbor vehicle add to the story?

Crane Harbor Acquisition Corp., the first vehicle, signed a transaction with Xanadu Quantum Technologies and completed that combination in March 2026. For CRAN, this history can support sponsor credibility because the same network has demonstrated an ability to source and execute a transaction. It also creates a governance issue: the annual report states that several officers and directors served both vehicles, and that Crane Harbor I had priority over certain opportunities until its combination. The first vehicle’s completion reduces that specific overlap, but the broader conflict risk remains because directors and affiliates may have other fiduciary and investment obligations.

Positive read-through
Execution experience
The team has prior public-market, energy, real-asset, and SPAC transaction experience, which may improve sourcing and process discipline.
Risk read-through
Shared obligations
Overlapping roles can influence opportunity allocation, time commitment, and the perceived independence of target selection.

What gives Crane Harbor II an edge in target selection?

A SPAC’s competitive advantage is not a product moat. It is a combination of sponsor reputation, sector access, transaction judgment, capital availability, and the ability to offer a private company a credible route to public markets. CRAN’s final IPO prospectus emphasizes large addressable markets, differentiated offerings, capable management, attractive unit economics, and a clear path to growth as preferred target attributes.

Which resources are potentially valuable?

Available trust capital — $348.539M at March 31, 2026Strong
Management transaction experienceStrong
Target specificity before announcementLimited
Pre-deal operating diversificationLimited

Who competes with CRAN?

Other SPAC sponsors
Target competition
They compete for private companies, PIPE capital, executives, and advisers; CRAN must differentiate through networks, speed, certainty, and sponsor credibility.
Strategic acquirers
Synergy advantage
Corporate buyers can offer operating synergies and cash; CRAN counters with public-market access, target autonomy, and flexible consideration.
Private equity buyers
Private execution
Sponsors offer financing and governance expertise; CRAN’s alternative is a listed currency and a potentially larger capital pool.
Traditional IPO or direct listing
Price discovery
Mature issuers may prefer a conventional listing; CRAN competes on negotiated valuation, timing, and transaction support.

The main strategic tension is therefore clear: broad flexibility expands the target universe, but it also prevents investors from evaluating industry-specific economics until a target is named. CRAN’s edge must be proven by the quality and terms of a future deal, not by the size of the trust alone.

Who owns CRAN and who controls governance?

Economic ownership and voting influence are not identical. Public investors supplied nearly all of the trust capital, but the founder-share structure gives the sponsor decisive pre-combination influence over board appointments. The 2025 Form 10-K reports 35.4 million Class A shares and 11.5 million Class B shares outstanding for beneficial-ownership purposes.

Holder or group Reported holding Reported ownership Governance significance
Crane Harbor Sponsor II / William Fradin 12.1M shares: 11.5M Class B plus 0.6M Class A 25.8% combined voting power in the 2025 Form 10-K Controls all founder shares and pre-deal director appointment rights.
Directors and executive officers as a group 12.1M shares attributed through the sponsor 25.8% combined voting power Incentives are closely tied to completing a transaction.
Meteora Capital 2,832,791 Class A shares at March 31, 2026 8.0% of Class A in the May 15, 2026 Schedule 13G Represents a material institutional position, but not sponsor control.
Adage Capital Management 2.7M Class A shares in the 2025 Form 10-K ownership table 7.6% of Class A; 5.8% combined voting power Adds institutional arbitrage and redemption sensitivity to the investor base.

Why does sponsor control matter?

The sponsor paid $25,000 for founder shares that can convert into 11.5 million Class A shares, subject to the charter’s adjustment provisions. At a hypothetical $10.00 value, those shares represent $115.0 million of implied value, creating a strong incentive to complete a transaction. The sponsor also purchased 600,000 placement units for $6.0 million. The official Schedule 13D confirms William Fradin’s shared voting and investment power through the sponsor.

What does institutional ownership signal?

Institutional positions in pre-deal SPACs often reflect cash-management, arbitrage, and redemption strategies rather than a long-term view on an operating company. Meteora’s May 2026 Schedule 13G reported 2.833 million shares, up from the 2.640 million reported at December 31, 2025. That ownership can influence redemption outcomes, but it should not be read as an endorsement of an unidentified future target.

Which KPIs matter most before CRAN announces a deal?

The most useful pre-deal KPIs measure capital preservation, liquidity runway, dilution, and transaction feasibility. Revenue, EBITDA, gross margin, customer growth, and backlog will become relevant only after a target is disclosed and consolidated financial information is available.

KPI Current reading How to interpret it
Trust value per public share $10.10 at March 31, 2026 Approximate redemption anchor before taxes and permitted withdrawals.
Outside-trust cash $1.953M at March 31, 2026 Funds diligence and reporting; falling liquidity can lead to sponsor loans.
Quarterly cash burn $0.225M operating cash use in Q1 2026 Shows the current search-cost run rate before a signed transaction.
Deferred underwriting fee $14.7M at March 31, 2026 A closing cost that reduces cash delivered to the combined company.
Potential rights dilution One share per 15 rights at closing Adds post-combination shares even when associated public shares were redeemed.
Founder-share base 11.5M Class B shares Key input for pro forma ownership and sponsor-promotion analysis.
Deadline runway Until December 17, 2027 Negotiating pressure generally increases as the completion window shortens.

How does valuation work for a pre-deal SPAC?

A conventional discounted cash flow cannot be built for CRAN alone because there are no operating forecasts. Before a target announcement, valuation is closer to a net-asset and option framework: trust value per share provides the cash anchor, while the market premium or discount reflects time value, redemption mechanics, sponsor quality, rights value, and expectations of a future transaction. After a deal is announced, the model must shift to the target’s revenue growth, margins, reinvestment, capital structure, dilution, and terminal economics.

Trust balance
Track quarterly trust growth and any permitted withdrawals; it anchors redemption value.
Outside cash and loans
Watch whether $1.953M of cash is sufficient or whether sponsor financing appears.
Target announcement
The target’s audited history, valuation, and capital needs will replace trust interest as the core analytical drivers.
Redemption rate
High redemptions can shrink closing cash and force PIPE, debt, or backstop financing.
Pro forma share count
Include founder conversion, rights, PIPE shares, seller shares, and any convertible loans.
Completion timetable
Measure progress against December 17, 2027 and any proposed extension vote.

What opportunities and risks could change CRAN’s outcome?

CRAN has substantial dry powder and a broad mandate, but the vehicle remains an option on management’s future judgment. The annual report’s risk factors emphasize deal-completion uncertainty, redemptions, dilution, conflicts, financing needs, regulatory change, foreign-target complexity, and the possibility that the post-combination company will depend on a single business.

Lower transaction uncertaintyHigher transaction uncertainty
High capital / lower uncertainty
A signed, fully financed transaction with low expected redemptions would move CRAN toward this quadrant.
High capital / higher uncertainty — CRAN today
The $348.539M trust is substantial, but no CRAN target was disclosed as of March 31, 2026.
Lower capital / lower uncertainty
A smaller but highly committed closing-capital package could fit here after redemptions are known.
Lower capital / higher uncertainty
Heavy redemptions, weak financing, or deadline pressure would push the vehicle toward this outcome.
Driver Potential upside Principal risk What to monitor
Large trust account Supports a meaningful transaction and post-close working capital. Redemptions can remove much of the cash before closing. Minimum-cash condition, redemption rate, and backstop financing.
Technology, real assets, and energy focus Access to sectors where the team has experience and networks. Cyclicality, capital intensity, regulation, or early-stage technology risk may be high. Target maturity, unit economics, customer concentration, and capex needs.
Flexible consideration Cash, equity, and debt can be tailored to target needs. PIPEs, debt, rights, and founder conversion can materially dilute public holders. Fully diluted pro forma ownership and cash delivered at closing.
Experienced sponsor May improve sourcing, diligence, and execution certainty. Low-cost founder shares can motivate completion of a weaker deal. Sponsor concessions, vesting, lockups, and board independence.
Completion window More than a year of runway remained after March 31, 2026. Targets gain negotiating leverage as December 17, 2027 approaches. Definitive agreement timing and any extension proposal.
Trust investments Short-term government securities preserve capital and generate interest. Lower rates reduce interest; investment-company concerns may require holding more cash. Trust yield, permitted withdrawals, and investment policy changes.

What is the most important strategic trade-off?

The sponsor must balance transaction speed against target quality. Waiting can preserve discipline but consumes outside cash and deadline runway. Moving quickly can secure a scarce asset but increase diligence, financing, or valuation risk. For students using a Five Forces or SWOT lens, the strongest current asset is financial flexibility; the largest weakness is the absence of an operating business; the main opportunity is a well-priced acquisition; and the central threat is a value-destructive deal completed under time or incentive pressure.

What is the key takeaway from CRAN analysis?

Crane Harbor Acquisition Corp. II is best understood as a capital-and-governance structure awaiting an operating identity. Its financial statements currently show strong trust protection, modest outside-trust cash consumption, and accounting profit generated by interest. They do not yet show a durable business model, competitive moat, customer base, or operating cash flow engine.

What should a student, researcher, or investor monitor next?

  • The identity, audited financials, and valuation of any announced target.
  • The redemption rate and actual cash remaining after the shareholder vote.
  • Founder-share treatment, rights dilution, PIPE pricing, debt, and seller rollover ownership.
  • Outside-trust liquidity, sponsor loans, transaction expenses, and the $14.7M deferred underwriting fee.
  • Board independence, conflicts, and whether management incentives are restructured around post-close performance.
  • Progress against the December 17, 2027 completion deadline.
CRAN’s current thesis is conditional, not operational.
The company matters because it controls a $348.539M trust account and is led by an experienced transaction team. Its opportunity is to convert that capital into a high-quality public business on disciplined terms. Its vulnerability is that sponsor economics, rights dilution, redemptions, financing needs, and deadline pressure can separate “a completed deal” from “a value-creating deal.” Until a target is disclosed, trust value and governance deserve more weight than reported net income.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(CRAN) Crane Harbor Acquisition Corp. II Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5